No Data
No Data
No Data
No Data
No Data
Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. Results were good overall, with
Simply Wall StApr 22 19:42 ET
The third generation of medicine has lost 150 billion
Growth is still ongoing
Gelonghui FinanceApr 21 05:23 ET
Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436) Investors Are Less Pessimistic Than Expected
When close to half the companies in China have price-to-earnings ratios (or "P/E's") below 31x, you may consider Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436) as a stock to avoid entirely
Simply Wall StMar 18 21:11 ET
Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Shareholders Have Earned a 17% CAGR Over the Last Five Years
Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436) shareholders might be concerned after seeing the share price drop 12% in the last quarter. But that doesn't change the fact that shareholde
Simply Wall StFeb 29 18:12 ET
Is Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Latest Stock Performance A Reflection Of Its Financial Health?
Zhangzhou Pientzehuang Pharmaceutical's (SHSE:600436) stock is up by a considerable 15% over the past week. Given the company's impressive performance, we decided to study its financial indicators m
Simply Wall StFeb 11 20:37 ET
Pientzehuang Pharmaceutical's Profit Climbs 12.6% in 2023
Zhangzhou Pientzehuang Pharmaceutical (SHA:600436) booked a net profit attributable to shareholders of 2.78 billion yuan, or 4.61 yuan per share, in 2023, up 12.6% from 2.47 billion yuan, 4.10 yuan pe
MT NewswiresJan 31 05:38 ET
No Data
No Data